Literature DB >> 21417260

Residue preference mapping of ligand fragments in the Protein Data Bank.

Lirong Wang1, Zhaojun Xie, Peter Wipf, Xiang-Qun Xie.   

Abstract

The interaction between small molecules and proteins is one of the major concerns for structure-based drug design because the principles of protein-ligand interactions and molecular recognition are not thoroughly understood. Fortunately, the analysis of protein-ligand complexes in the Protein Data Bank (PDB) enables unprecedented possibilities for new insights. Herein, we applied molecule-fragmentation algorithms to split the ligands extracted from PDB crystal structures into small fragments. Subsequently, we have developed a ligand fragment and residue preference mapping (LigFrag-RPM) algorithm to map the profiles of the interactions between these fragments and the 20 proteinogenic amino acid residues. A total of 4032 fragments were generated from 71 798 PDB ligands by a ring cleavage (RC) algorithm. Among these ligand fragments, 315 unique fragments were characterized with the corresponding fragment-residue interaction profiles by counting residues close to these fragments. The interaction profiles revealed that these fragments have specific preferences for certain types of residues. The applications of these interaction profiles were also explored and evaluated in case studies, showing great potential for the study of protein-ligand interactions and drug design. Our studies demonstrated that the fragment-residue interaction profiles generated from the PDB ligand fragments can be used to detect whether these fragments are in their favorable or unfavorable environments. The algorithm for a ligand fragment and residue preference mapping (LigFrag-RPM) developed here also has the potential to guide lead chemistry modifications as well as binding residues predictions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21417260      PMCID: PMC3081969          DOI: 10.1021/ci100386y

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  23 in total

1.  SuperStar: a knowledge-based approach for identifying interaction sites in proteins.

Authors:  M L Verdonk; J C Cole; R Taylor
Journal:  J Mol Biol       Date:  1999-06-18       Impact factor: 5.469

2.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

3.  Discovering novel ligands for macromolecules using X-ray crystallographic screening.

Authors:  V L Nienaber; P L Richardson; V Klighofer; J J Bouska; V L Giranda; J Greer
Journal:  Nat Biotechnol       Date:  2000-10       Impact factor: 54.908

4.  Protein isoelectric point as a predictor for increased crystallization screening efficiency.

Authors:  Katherine A Kantardjieff; Bernhard Rupp
Journal:  Bioinformatics       Date:  2004-02-10       Impact factor: 6.937

5.  Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés".

Authors:  Eric-Wubbo Lameijer; Joost N Kok; Thomas Bäck; Ad P Ijzerman
Journal:  J Chem Inf Model       Date:  2006 Mar-Apr       Impact factor: 4.956

6.  Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase.

Authors:  Anthony Addlagatta; Brian W Matthews
Journal:  Protein Sci       Date:  2006-07-05       Impact factor: 6.725

7.  Differences between high- and low-affinity complexes of enzymes and nonenzymes.

Authors:  Heather A Carlson; Richard D Smith; Nickolay A Khazanov; Paul D Kirchhoff; James B Dunbar; Mark L Benson
Journal:  J Med Chem       Date:  2008-10-01       Impact factor: 7.446

8.  DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Authors:  David S Wishart; Craig Knox; An Chi Guo; Savita Shrivastava; Murtaza Hassanali; Paul Stothard; Zhan Chang; Jennifer Woolsey
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

9.  The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics.

Authors:  Christoph Steinbeck; Yongquan Han; Stefan Kuhn; Oliver Horlacher; Edgar Luttmann; Egon Willighagen
Journal:  J Chem Inf Comput Sci       Date:  2003 Mar-Apr

10.  DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Authors:  David S Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali
Journal:  Nucleic Acids Res       Date:  2007-11-29       Impact factor: 16.971

View more
  7 in total

1.  Development and Testing of Druglike Screening Libraries.

Authors:  Junmei Wang; Yubin Ge; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-01-03       Impact factor: 4.956

2.  Inverse Mixed-Solvent Molecular Dynamics for Visualization of the Residue Interaction Profile of Molecular Probes.

Authors:  Keisuke Yanagisawa; Ryunosuke Yoshino; Genki Kudo; Takatsugu Hirokawa
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Considerations of Protein Subpockets in Fragment-Based Drug Design.

Authors:  Matthew Bartolowits; V Jo Davisson
Journal:  Chem Biol Drug Des       Date:  2015-08-31       Impact factor: 2.817

Review 4.  Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications.

Authors:  Yuemin Bian; Xiang-Qun Sean Xie
Journal:  AAPS J       Date:  2018-04-09       Impact factor: 4.009

5.  CAVIAR: a method for automatic cavity detection, description and decomposition into subcavities.

Authors:  Jean-Rémy Marchand; Bernard Pirard; Peter Ertl; Finton Sirockin
Journal:  J Comput Aided Mol Des       Date:  2021-05-29       Impact factor: 3.686

6.  Knowledge-based fragment binding prediction.

Authors:  Grace W Tang; Russ B Altman
Journal:  PLoS Comput Biol       Date:  2014-04-24       Impact factor: 4.475

7.  Identification of Histamine H3 Receptor Ligands Using a New Crystal Structure Fragment-based Method.

Authors:  Ida Osborn Frandsen; Michael W Boesgaard; Kimberley Fidom; Alexander S Hauser; Vignir Isberg; Hans Bräuner-Osborne; Petrine Wellendorph; David E Gloriam
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.